Meike Adam

1.0k total citations
22 papers, 438 citations indexed

About

Meike Adam is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Meike Adam has authored 22 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Meike Adam's work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Renal cell carcinoma treatment (3 papers). Meike Adam is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Renal cell carcinoma treatment (3 papers). Meike Adam collaborates with scholars based in Germany and Switzerland. Meike Adam's co-authors include Thorsten Schlomm, Guido Sauter, Markus Graefen, Sarah Minner, Hartwig Huland, Ronald Simon, Maria Christina Tsourlakis, Katharina Grupp, Stefan Steurer and Stefan Steurer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Urology.

In The Last Decade

Meike Adam

21 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meike Adam Germany 11 292 217 127 72 50 22 438
Cristoforo Cama United States 6 401 1.4× 220 1.0× 126 1.0× 80 1.1× 50 1.0× 7 509
V.J. Gnanapragasam United Kingdom 10 179 0.6× 201 0.9× 59 0.5× 70 1.0× 36 0.7× 18 388
W. P. Peelen Netherlands 9 212 0.7× 150 0.7× 85 0.7× 62 0.9× 100 2.0× 14 400
Sandra Waalkes Germany 12 217 0.7× 234 1.1× 82 0.6× 79 1.1× 81 1.6× 27 407
Ryo Inoue Japan 10 115 0.4× 233 1.1× 94 0.7× 117 1.6× 126 2.5× 33 411
Shengming Jin China 13 165 0.6× 290 1.3× 210 1.7× 74 1.0× 84 1.7× 32 481
DUQUN CHEN China 15 91 0.3× 361 1.7× 332 2.6× 39 0.5× 64 1.3× 31 538
Charles R. Sikes United States 10 262 0.9× 122 0.6× 72 0.6× 175 2.4× 27 0.5× 12 402
Xiuling Wu China 13 100 0.3× 196 0.9× 125 1.0× 61 0.8× 65 1.3× 31 347
Vérane Achard Switzerland 10 263 0.9× 79 0.4× 71 0.6× 87 1.2× 24 0.5× 37 359

Countries citing papers authored by Meike Adam

Since Specialization
Citations

This map shows the geographic impact of Meike Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meike Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meike Adam more than expected).

Fields of papers citing papers by Meike Adam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meike Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meike Adam. The network helps show where Meike Adam may publish in the future.

Co-authorship network of co-authors of Meike Adam

This figure shows the co-authorship network connecting the top 25 collaborators of Meike Adam. A scholar is included among the top collaborators of Meike Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meike Adam. Meike Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Loeb, Stacy, Meike Adam, Pierre Tennstedt, et al.. (2016). Toxicity in a multimodality approach of radical prostatectomy with radiation and hormonal therapy.. Journal of Clinical Oncology. 34(2_suppl). 107–107. 1 indexed citations
3.
Melling, Nathaniel, Claudia Hube‐Magg, Martina Kluth, et al.. (2015). High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer. PLoS ONE. 10(7). e0134614–e0134614. 14 indexed citations
4.
Grupp, Katharina, Martina Kluth, Claudia Hube‐Magg, et al.. (2015). Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion. Oncology Reports. 34(3). 1211–1220. 10 indexed citations
5.
Adam, Meike, Christoph Burdelski, Waldemar Wilczak, et al.. (2015). HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy. Oncotarget. 6(14). 12822–12834. 31 indexed citations
6.
Kluth, Martina, Jazan Omari, Stefan Steurer, et al.. (2015). Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer. International Journal of Cancer. 137(10). 2354–2363. 26 indexed citations
7.
Burdelski, Christoph, Ronald Simon, Claudia Hube‐Magg, et al.. (2014). Saccharomyces cerevisiae–like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion–positive and fusion-negative cancers. Human Pathology. 46(4). 514–523. 8 indexed citations
8.
Ivanyi, Philipp, Thomas Fuehner, Meike Adam, et al.. (2014). Interstitial lung disease during targeted therapy in metastatic renal cell carcinoma: a case series from three centres. Medical Oncology. 31(9). 147–147. 5 indexed citations
9.
Becker, Andreas, Meike Adam, Pierre Tennstedt, et al.. (2014). Safe-R: a novel score, accounting for oncological safe nerve-sparing at radical prostatectomy for localized prostate cancer. World Journal of Urology. 33(1). 77–83. 1 indexed citations
10.
Grupp, Katharina, Maria Christina Tsourlakis, Christina Koop, et al.. (2014). NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer. The Prostate. 74(10). 1012–1022. 6 indexed citations
11.
Adam, Meike, Lars Budäus, Thomas Steuber, et al.. (2014). A Tertiary Gleason Pattern in the Prostatectomy Specimen and its Association with Adverse Outcome after Radical Prostatectomy. The Journal of Urology. 192(1). 97–102. 28 indexed citations
12.
Grupp, Katharina, Maria Christina Tsourlakis, Christina Koop, et al.. (2014). The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG‐negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression. International Journal of Cancer. 135(6). 1399–1407. 20 indexed citations
13.
Stumm, Laura, Lia Burkhardt, Stefan Steurer, et al.. (2013). Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers. Journal of Clinical Pathology. 66(7). 563–568. 21 indexed citations
14.
Froehner, Michael, Rainer Koch, Manfred P. Wirth, et al.. (2013). Does increasing life expectancy affect competing mortality after radical prostatectomy?. Urologic Oncology Seminars and Original Investigations. 32(4). 413–418. 6 indexed citations
15.
Beyer, Burkhard, Thorsten Schlomm, Pierre Tennstedt, et al.. (2013). A Feasible and Time-efficient Adaptation of NeuroSAFE for da Vinci Robot-assisted Radical Prostatectomy. European Urology. 66(1). 138–144. 79 indexed citations
16.
Grupp, Katharina, Maria Christina Tsourlakis, Christina Koop, et al.. (2013). High mitochondria content is associated with prostate cancer disease progression. Molecular Cancer. 12(1). 145–145. 50 indexed citations
17.
Krohn, Antje, Lia Burkhardt, Malte Mäder, et al.. (2013). Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion‐positive prostate cancers. The Journal of Pathology. 231(1). 130–141. 71 indexed citations
18.
Ivanyi, Philipp, Thomas Fuehner, Meike Adam, et al.. (2013). Interstitial lung diseases during treatment with sunitinib or mTOR inhibitors in metastatic renal cell carcinoma.. Journal of Clinical Oncology. 31(6_suppl). 420–420.
19.
Eichelberg, Christian, Felix K.‐H. Chun, Jens Bedke, et al.. (2012). Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma. International Journal of Cancer. 132(12). 2948–2955. 20 indexed citations
20.
Grupp, Katharina, Sebastian Kohl, Hüseyin Sirma, et al.. (2012). Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence. Modern Pathology. 26(5). 733–742. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristoforo Cama Breakdown of academic impact, for papers by V.J. Gnanapragasam Breakdown of academic impact, for papers by W. P. Peelen Breakdown of academic impact, for papers by Sandra Waalkes Breakdown of academic impact, for papers by Ryo Inoue Breakdown of academic impact, for papers by Shengming Jin Breakdown of academic impact, for papers by DUQUN CHEN Breakdown of academic impact, for papers by Charles R. Sikes Breakdown of academic impact, for papers by Xiuling Wu Breakdown of academic impact, for papers by Vérane Achard
Rankless by CCL
2026